Home  /  Resource Library  /  Retrospective Analysis of the Efficacy and Tolerability of Gemcitabine-based Chemotherapy in Relapsed/Refractory Lymphoma Patients Not Eligible for Stem Cell Transplant

Retrospective Analysis of the Efficacy and Tolerability of Gemcitabine-based Chemotherapy in Relapsed/Refractory Lymphoma Patients Not Eligible for Stem Cell Transplant

Retrospective study examined gemcitabine based chemotherapy for treatment of relapsed lymphomas. (Abstract only)